Bioavailability Challenge 2013: Frost & Sullivan is Set to Participate as Keynote Speaker

Published: Mar 14, 2013

March 14, 2013 -- Frost & Sullivan will present global trends, challenges and opportunities at Bioavailability Challenge 2013 webinar next week

Online event on the 20th of March - Top representatives from the pharmaceutical and biopharmaceutical industry are confirmed to attend the Bioavailability Challenge 2013 virtual event, which will gather a global audience to watch and interact in a series of highly informative live webinars.

Deepika Pramod Chopda, Frost & Sullivan Research Analyst for Healthcare, is set to participate as keynote speaker focusing on challenges and opportunities in bioavailability and service overview from the CROs.

It is a well-established principle that even the most promising API can only be turned into an effective and marketable drug if formulated in such a way that it reaches the blood stream.

Finding the solution to this bioavailability problem is still a major headache for pharmaceutical firms. Such difficulties are likely to become a common experience for teams developing new drugs, as pharmaceutical company pipelines increasingly fill with candidates based on biopharmaceutics classification system (BCS) class II and IV compounds. Difficulties are not limited to firms developing new drugs, as generic drugmakers also face their own bioavailability challenges.

Strict regulatory requirements on bioequivalence testing mean more trials, more analysis and more formulation development work, all of which increase cost and length of time it takes to bring a non-branded product to market. Similarly, biopharmaceutical firms hoping to develop oral delivery alternatives for injectable biologics will also need to work out how to ensure that their products are bioavailable, safe and effective.

Bioavailability Challenge 2013, which is organised by the leading online pharmaceutical publications and, will bring together top pharmaceutical, biotechnology, academic and regulatory representatives under one roof, who will address the industry key issues, identifying market opportunities and sharing innovations. The event will take place online on the 20th of March.

How to attend

The event is free, simply register by clicking on the following link:

For more information contact

About and breaks key news in pharmaceutical manufacturing, technology and drug delivery in a landscape of shifting regulation and globalisation. Our coverage spans every aspect of the industry, from ingredients to regulations, drug delivery to processing technology, keeping readers briefed on all the must-know developments. is a free online news service covering the full spectrum of contract services to the pharmaceutical and biotechnology industries, from contract research and development through to manufacturing and commercial services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion


Marie-Cecile de Faucigny

Account Manager - Online Marketing Solutions

William Reed Business Media

P: +33 4 99 52 83 08


Anna Zanchi

Corporate Communications – Europe

Frost & Sullivan

P: +39.02.4851 6133


Back to news